Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 19340 [2014-07775]

Download as PDF 19340 Federal Register / Vol. 79, No. 67 / Tuesday, April 8, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK4VPTVN1PROD with NOTICES Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Time and Date: 8:30 a.m.–3:00 p.m. (EST), April 24, 2014. Place: CDC, Building 21, Rooms 1204 A/B, 1600 Clifton Road NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space and phone lines available. The meeting room accommodates approximately 50 people. The public is welcome to participate during the public comment period, tentatively scheduled from 2:45 p.m. to 2:50 p.m. This meeting is also available by teleconference. Please dial (877) 930–8819 and enter code 1579739. Web links: Connection-1: https:// wm.onlinevideoservice.com/CDC1 Flash Connection-3 (For Safari and Google Chrome Users): https:// www.onlinevideoservice.com/clients/ CDC/?mount=CDC3 If you are unable to connect using the link, copy and paste the link into your web browser. Captions are only available on the Windows Media links (Connections 1). Viewer’s report is given the next day. Number for Technical Support: (404) 639–3737. Purpose: The committee will provide advice to the CDC Director on strategic and other broad issues facing CDC. Matters for Discussion: The Advisory Committee to the Director will receive updates from the State, Tribal, Local and Territorial Subcommittee; the Health Disparities Subcommittee, the Global Workgroup, and the Public Health—Health Care Collaboration Workgroup; as well as an update from the CDC Director. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Carmen Villar, MSW, Designated Federal Officer, ACD, CDC, 1600 Clifton Road NE., M/S D–14, Atlanta, Georgia 30333. Telephone: (404) 639–7000, Email: GHickman@cdc.gov. The deadline for notification of attendance is April 17, 2014. To register for this meeting, please send an email to ACDirector@cdc.gov. The Director, Management Analysis and Services Office, has been delegated VerDate Mar<15>2010 16:42 Apr 07, 2014 Jkt 232001 the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–07774 Filed 4–7–14; 8:45 am] Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–07775 Filed 4–7–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), HHS. Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Collaboration on Climate Sensitive Diseases and Health Effects, Funding Opportunity Announcement (FOA) CK14–003, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1:00 p.m.–3:00 p.m., April 22, 2014 (Closed) Place: Teleconference Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Collaboration on Climate Sensitive Diseases and Health Effects, FOA CK14– 003’’. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 8:15 a.m.–5:15 p.m., EST, April 29, 2014. Public Comment Time and Date: 5:15 p.m.–6:15 p.m.*, EST, April 29, 2014. *Please note that the public comment period may end before the time indicated, following the last call for comments. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Place: Augusta Marriott, 2 10th Street, Augusta, Georgia 30901; Phone: (800)868–5354; Fax: (706) 724–0044. Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1– 866–659–0537 with a pass code of 9933701. Live Meeting Connection: https://www.livemeeting.com/cc/cdc/ join?id=7CSBK8&role= attend&pw=ABRWH; Meeting ID: 7CSBK8; Entry Code: ABRWH. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 150 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human E:\FR\FM\08APN1.SGM 08APN1

Agencies

[Federal Register Volume 79, Number 67 (Tuesday, April 8, 2014)]
[Notices]
[Page 19340]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-07775]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Collaboration on Climate 
Sensitive Diseases and Health Effects, Funding Opportunity Announcement 
(FOA) CK14-003, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 1:00 p.m.-3:00 p.m., April 22, 2014 (Closed)
    Place: Teleconference
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Collaboration on Climate Sensitive Diseases and Health Effects, 
FOA CK14-003''.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833. The Director, 
Management Analysis and Services Office, has been delegated the 
authority to sign Federal Register notices pertaining to announcements 
of meetings and other committee management activities, for both the 
Centers for Disease Control and Prevention and the Agency for Toxic 
Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-07775 Filed 4-7-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.